Engineering nanoparticles for macrophage reprogramming in chronic inflammatory diseases: current advances, challenges, and future perspectives
Frontiers in Bioengineering and Biotechnology · 11.08.2026 · 14
DOI: 10.3389/fbioe.2026.1900076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 11.08.2026. Verfasst von Shreya Bharti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mehta Family School of Biosciences and Biomedical Engineering (MFSBSBE), Indian Institute of Technology Indore (IITI), Indore, Madhya Pradesh, India. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammation is essential for host defense and tissue repair, yet its dysregulation contributes to the development of numerous chronic diseases. Macrophages play a central role in these processes through their remarkable functional plasticity and ability to adopt pro-inflammatory or pro-resolving states. Nanoparticles have emerged as promising immunomodulatory platforms capable of reprogramming macrophage function through precisely engineered physicochemical properties. This review examines how nanoparticle characteristics, including size, surface charge, surface functionalization, biomimetic coatings, and microenvironment-responsive features, influence macrophage reprogramming across diverse chronic inflammatory diseases. Comparative analysis reveals that successful nanoplatforms frequently target conserved inflammatory pathways, including NF-κB, NLRP3, HIF-1α, and oxidative stress-associated pathways. We further highlight emerging structure-function relationships, translational challenges, and key design principles that can guide the development of next-generation nanotherapeutics aimed at restoring homeostasis in chronic inflammatory diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mehta Family School of Biosciences and Biomedical Engineering (MFSBSBE), Indian Institute of Technology Indore (IITI), Indore, Madhya Pradesh, India.
- Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN, United States.
- Divisional Railway Hospital, Central Railway, Nagpur, Maharashtra, India.
- Institute of Evolutionary Medicine, University of Zurich, Zurich, Switzerland.
- Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University, Rome, Italy.
Zitieren
APA
Bharti, S., Obukhov, A. G., Zafar, S., Saso, L., & Baig, M. S. (2026). Engineering nanoparticles for macrophage reprogramming in chronic inflammatory diseases: current advances, challenges, and future perspectives. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1900076
Vancouver
Bharti S, Obukhov AG, Zafar S, Saso L, Baig MS. Engineering nanoparticles for macrophage reprogramming in chronic inflammatory diseases: current advances, challenges, and future perspectives. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1900076
BibTeX
@article{Bharti2026,
author = {Bharti, Shreya and Obukhov, Alexander G and Zafar, Sabahat and Saso, Luciano and Baig, Mirza S},
title = {Engineering nanoparticles for macrophage reprogramming in chronic inflammatory diseases: current advances, challenges, and future perspectives},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1900076}
}
EUVIMED